small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniDiversity, Equity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 47 results

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Industry

Financial Crimes Compliance

Winston’s financial crimes compliance lawyers have been providing regulatory compliance counseling and enforcement services related to the Bank Secrecy Act (BSA), the Anti-Money Laundering Act of 2020 (AML), and countering the financing of terrorism (CFT) policy for decades. We also have experience with international AML matters, including in the EU and with respect to Financial Actions Task Force (FATF) recommendations....Read more

Practice Area

Securities, M&A & Corporate Governance Litigation

In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors....Read more

Insights & News 2,727 results

Client Alert

|

December 5, 2024

|

10+ Min Read

CFPB Issues Open Banking Rule Making It Easier for Customers to “Divorce” Their Banks

On October 22, 2024, the Consumer Financial Protection Bureau (CFPB) issued a final rule to enforce consumers’ personal financial data access rights granted to them by Section 1033 of the Consumer Financial Protection Act (CFPA), 12 U.S.C. § 5553 (the Rule). Commonly referred to as the “open banking” rule, the Rule is intended to offer consumers the ability to easily switch between providers of financial services and products, increase innovation and greater quality in services, and create baseline security standards for sharing and accessing information across the market....Read more

Client Alert

|

December 4, 2024

|

4 Min Read

Federal Judge in Texas Blocks Enforcement of the Corporate Transparency Act Nationwide

Unless a legal entity created in or registered to do business in the United States before 2024 can satisfy one of the few and relatively narrow exemptions from reporting its beneficial ownership information (BOI) to the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN), such legal entity – a reporting company – has until Wednesday, January 1, 2025 to file its BOI report with FinCEN. The BOI report is required under the Corporate Transparency Act (CTA) and the BOI reporting rule that FinCEN issued pursuant to the CTA (BOI Reporting Rule). Failure to timely file, amend or correct a BOI report with FinCEN subjects the reporting company to potential civil, and in some cases criminal, penalties from FinCEN.

In the Media

|

December 4, 2024

|

Less Than 1 Min Read

Winston Partner to Join Webinar On Consolidated Appropriations Act

On December 4, 2024, Winston Partner Amy Gordon will be participating in a webinar discussing the Consolidated Appropriations Act (CAA).  Amy, along with a team of industry experts, will discuss:...Read more
View All Insights & News

Other Results 30 results

Site Content

What Is Failure to Warn?

In the product liability context, a failure to warn claim arises when a plaintiff alleges that a product lacked an adequate warning regarding potential risks associated with its use. To succeed in a failure to warn claim, a plaintiff typically needs to demonstrate that the lack of a warning regarding a particular potential harm rendered the product unreasonably dangerous, and that adequate warnings would have ultimately prevented the alleged harm....Read more

Law Glossary

What Is Consumer Privacy Law?

Consumer privacy law is the legal area covering violations of personal information and the right to privacy in everyday life, including violations relating to technology use and finances. Consumer privacy laws and regulations protect individuals from privacy loss due to the failures and limitations of corporate customer privacy measures. The Federal Trade Commission (FTC) is the primary agency directing federal privacy policies and enforcing associated regulations. The FTC utilizes law enforcement, creates policy, and educates consumers as it acts to protect privacy. Legal action can be taken against organizations that violate consumer privacy rights, especially regarding sensitive information....Read more

Site Content

What Is General Causation?

In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2024. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceEqual Rights AmendmentLaw GlossaryNew Administration: The Transition Period UpdateWinston MinutePrivacy PolicyCookie PolicyNoticesSubscribeAttorney Advertising